FDA Never Inspected Chinese Heparin Plants Medical Video by Pharmacy

FDA Never Inspected Chinese Heparin Plants

Pharmacy

Currently 0.00/5
1
2
3
4
5

Rating: 0.0 out of 0 votes

Comments (0)

You need to have the Flash Player installed and a browser with JavaScript support.

Description

http://www.heparinrecall.info If you've been hurt by heparin, you may be entitled to a cash settlement. Additional details about Baxter Healthcare Corporations, urgent recall of Heparin, a prescription injectable blood coagulant often used in hemodialysis (the filtering of blood) and cardiac invasive procedures, on January 25th 2008 are now being released. The Food and Drug Administration (FDA) has reported that it never inspected the Chinese manufacturing plant that provides Baxter with the active ingredient of the drug. FDA admission According to several news sources, the FDA, already under scrutiny for not adequately protecting the public against many harmful drugs and defective medical devices, admitted that it did not inspect the Chinese plant that provides Baxter with Heparins active ingredient an enzyme taken from pig intestines which has been linked to several adverse reactions to the drug. The active ingredient is shipped to a Baxter facility in New Jersey where the final manufacturing process is completed. Baxter has reported that it inspected the plant outside of Shanghai, China less than months beforehand and that it plans to inspect it again based on this latest report.